Manufacturer
104 recalls in our database name Wells Pharmacy Network, LLC as the manufacturing or recalling firm.
Of the 104 recalls from Wells Pharmacy Network, LLC we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 93 (89%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Wells Pharmacy Network LLC is recalling 44 vials of Carnitine-L 250 mg/mL Injectable due to a lack of assurance of sterility. The product was distributed nationwide.
Wells Pharmacy Network LLC is recalling 189 vials of Leucine/Isoleucine/Valine Injectable due to a lack of assurance of sterility. The product was distributed nationwide.
Wells Pharmacy Network LLC is recalling 265 vials of compounded Methylcobalamin 5,000 mcg/mL Injectable because the product lacks assurance of sterility.
Wells Pharmacy Network LLC is recalling specific lots of Trimix with Atropine Injectable because the agency could not ensure the product was sterile.
Wells Pharmacy Network LLC is recalling Sermorelin Acetate/GHRP Injectable Kits nationwide because the agency cannot assure the product is sterile.
Wells Pharmacy Network LLC is recalling 1,968 vials of Phenylephrine HCl Injectable due to a lack of assurance of sterility. The product was distributed nationwide.
Wells Pharmacy is recalling 330 Sermorelin Acetate 28 mg Injectable Kits nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling Trimix with Atropine Injectable vials due to a lack of assurance of sterility. The recall covers products prepared between February 2016 and September 2016.
Wells Pharmacy is recalling 568 Sermorelin Acetate 15 mg Injectable Kits nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 469 vials of compounded Testosterone Propionate Injectable because the agency could not ensure the product was sterile.
Wells Pharmacy Network LLC is recalling Alprostadil 20 mcg/mL Injectable vials due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling Sermorelin Acetate/GHRP (6) injectable kits nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling compounded Testosterone Cypionate in Sesame Oil Injectable vials due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling Sermorelin Acetate/GHRP (2) Injectable Kits because the agency could not ensure the products were sterile.
Wells Pharmacy Network LLC is recalling 157 vials of Ultra-Test Injectable nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 2,339 compounded Chorionic Gonadotropin Injectable Kits nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 908 compounded Chorionic Gonadotropin Injectable Kits nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling B-complex + Vit C injectable vials due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling compounded Chorionic Gonadotropin injectable kits due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling MIC Combo injectable vials because the agency could not ensure the product was sterile.
Wells Pharmacy Network LLC is recalling 526 vials of compounded Nandrolone Decanoate injectable nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network LLC is recalling 1,716 vials of a compounded injectable product nationwide due to a lack of assurance of sterility.
Wells Pharmacy Network is recalling Testosterone 60 mg/Anastrazole 4 mg Pellets because they were found to be superpotent or subpotent.
Wells Pharmacy Network is recalling Testosterone 200 mg/Anastrazole 20mg Pellets because they may be superpotent or subpotent.
Wells Pharmacy Network is recalling compounded Testosterone 200 mg/Anastrozole 9 mg Pellets because they are superpotent or subpotent.